Aug 23 (Reuters) - CSPC Pharmaceutical Group Ltd :
* EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN CHINA
* UNIT TO PAY AN UPFRONT PAYMENT OF RMB150 MILLION & DEVELOPMENT MILESTONE PAYMENTS OF UP TO RMB450 MILLION FOR DEAL
Further company coverage:
精彩评论